• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    FDA Confirms Paragraph IV Patent Litigation for Amifampridine Phosphate Tablets

    FDA

    Serb SA`s Amifampridine Serb (amifampridine) Receives Approval in Europe

    EMA

    KYE Pharmaceuticals Announces Commercial Availability of FIRDAPSE in Canada

    BIOSPACE

    Catalyst Pharma and KYE Pharmaceuticals Announce Agreement to Make Firdapse®

    GLOBENEWSWIRE

    Catalyst Pharmaceuticals’ Firdapse® Receives Marketing Approval in Canada

    GLOBENEWSWIRE

    Catalyst`s lead candidate Firdapse falls short Congenital Myasthenic Syndromes

    PHARMAFILE

    Catalyst Pharma sees net price of drug, once free, topping $300,000

    REUTERS

    Catalyst Announces FDA Acceptance NDA and Priority Review Status for Firdapse®

    GLOBENEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.